Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Chugai Pharmaceutical
ClinicalTrials.gov Identifier:
NCT00447915
First received: March 14, 2007
Last updated: July 31, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)